About Amaxa Biosystems
Amaxa Biosystems is a company based in Koln (Germany) founded in 1998. Amaxa Biosystems has raised $11.6 million across 1 funding round from investors including NRW.Bank, 3i Group and Earlybird. Amaxa Biosystems offers products and services including Integrated Biologics and Advanced Synthesis.
- Total Equity Funding$11.6M (USD)
in 1 rounds
- Latest Funding Round$11.6M (USD), Series A
Jun 2001
- InvestorsNRW.Bank
& 2 more
Products & Services of Amaxa Biosystems
Amaxa Biosystems offers a comprehensive portfolio of products and services, including Integrated Biologics and Advanced Synthesis.
End-to-end offerings in mammalian development and manufacturing are provided to accelerate and de-risk the path to market.
High-quality small molecules and HPAPIs are manufactured to support drug development and production processes.
Apps and channels of Amaxa Biosystems
its YouTube channel Lonza has 4.15K subscribers and 30 videos.
Videos from Amaxa Biosystems
The most watched videos on Amaxa Biosystems's YouTube channel, Lonza (4.15K subscribers). Click a video to play it here.
More on Lonza.
Funding Insights of Amaxa Biosystems
Amaxa Biosystems has successfully raised a total of $11.6M through 1 strategic funding round. The most recent funding activity was a Series A round of $11.6 million completed in June 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11.6M
- Total Rounds 1
- Last Round Series A — $11.6M
- First Round $11.6M
(Jun 2001)
- Investors Count 3
All 1 funding rounds of Amaxa Biosystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Amaxa Biosystems
Amaxa Biosystems has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include NRW.Bank, 3i Group and Earlybird.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on mid-market businesses | 1945 | 3i.com | London, United Kingdom | |
Earlybird is recognized as a venture capital investor focused on early-stage tech companies. | – | earlybird.com | Berlin, Germany | |
Loans, advice, seminars, and networks are provided for financial support. | 2001 | nrwbank.de | Dusseldorf, Germany |
Investor details for Amaxa Biosystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Amaxa Biosystems
2 dated milestones of Amaxa Biosystems across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Amaxa Biosystems is founded.
- Funding First funding round of $11.6M.
Web traffic of Amaxa Biosystems
Websites that share an audience with Amaxa Biosystems (amaxa.com).
Websites whose visitors overlap most with Amaxa Biosystems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| invitrogen.com | 100% | 5.2K | #3,688,642 | View details | |
wicell.org | wicell.org | 82% | – | #2,266,936 | – |
premierbiosoft.com | premierbiosoft.com | 82% | – | #1,258,936 | – |
| oxfordbiomed.com | 82% | 3.8K | #4,977,915 | View details | |
| bdbiosciences.com | 82% | 331.8K | #154,504 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Amaxa Biosystems
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Amaxa Biosystems
Complete news archive for Amaxa Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Amaxa Biosystems
10 companies that operate in the same segment as Amaxa Biosystems (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Amaxa Biosystems
Amaxa Biosystems was founded in 1998 and raised its 1st funding round 3 years after it was founded.
Amaxa Biosystems is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.
Amaxa Biosystems is a funded company, having raised a total of $11.6M across 1 funding round to date. The company's 1st funding round was a Series A of $11.6M, raised on Jun 2001.
Amaxa Biosystems was founded in 1998 in Cologne, Germany, as a supplier to pharmaceutical, biotechnology, and specialty ingredients sectors. Active pharmaceutical ingredients, stem-cell therapies, preservatives, microbial control solutions, vitamin B compounds, and personal care ingredients were offered, along with custom development and manufacturing services. Expertise was held in non-viral transfection technologies, particularly the Nucleofector method for DNA and siRNA delivery into hard-to-transfect cells. Acquisition by Lonza occurred in 2008.
Amaxa Biosystems offers Integrated Biologics and Advanced Synthesis.
Amaxa Biosystems operates through Lonza Group Ag.